112 related articles for article (PubMed ID: 34688332)
1. Ophthalmic Delivery of Riboflavin Loaded Nanoparticulate Suspension in Keratoconus: A Preclinical Study in Rabbit Model.
Zhang L; Fang C; Wu Q
J Biomed Nanotechnol; 2021 Sep; 17(9):1866-1873. PubMed ID: 34688332
[TBL] [Abstract][Full Text] [Related]
2. Studying the influence of formulation and process variables on Vancomycin-loaded polymeric nanoparticles as potential carrier for enhanced ophthalmic delivery.
Yousry C; Elkheshen SA; El-Laithy HM; Essam T; Fahmy RH
Eur J Pharm Sci; 2017 Mar; 100():142-154. PubMed ID: 28089661
[TBL] [Abstract][Full Text] [Related]
3. Loteprednol Etabonate Nanoparticles: Optimization via Box-Behnken Design Response Surface Methodology and Physicochemical Characterization.
Sah AK; Suresh PK
Curr Drug Deliv; 2017; 14(5):676-689. PubMed ID: 27480117
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen-bonded complexes and blends of poly(acrylic acid) and methylcellulose: nanoparticles and mucoadhesive films for ocular delivery of riboflavin.
Khutoryanskaya OV; Morrison PW; Seilkhanov SK; Mussin MN; Ozhmukhametova EK; Rakhypbekov TK; Khutoryanskiy VV
Macromol Biosci; 2014 Feb; 14(2):225-34. PubMed ID: 24106128
[TBL] [Abstract][Full Text] [Related]
5. Formulation and Evaluation of Atorvastatin Calcium-Poly-ε-Caprolactone Nanoparticles Loaded Ocular Inserts for Sustained Release and Antiinflammatory Efficacy.
Girgis GNS
Curr Pharm Biotechnol; 2020; 21(15):1688-1698. PubMed ID: 32427080
[TBL] [Abstract][Full Text] [Related]
6. Development of a Chitosan-based Nanoparticle Formulation for Ophthalmic Delivery of Honokiol.
Deng F; Hu W; Chen H; Tang Y; Zhang L
Curr Drug Deliv; 2018; 15(4):594-600. PubMed ID: 28425869
[TBL] [Abstract][Full Text] [Related]
7. Exploring gelatin nanoparticles as novel nanocarriers for Timolol Maleate: Augmented in-vivo efficacy and safe histological profile.
Shokry M; Hathout RM; Mansour S
Int J Pharm; 2018 Jul; 545(1-2):229-239. PubMed ID: 29709617
[TBL] [Abstract][Full Text] [Related]
8. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Katara R; Sachdeva S; Majumdar DK
Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843
[TBL] [Abstract][Full Text] [Related]
9. Studying the ophthalmic toxicity potential of developed ketoconazole loaded nanoemulsion
Tavakoli M; Mahboobian MM; Nouri F; Mohammadi M
Toxicol Mech Methods; 2021 Oct; 31(8):572-580. PubMed ID: 34126859
[TBL] [Abstract][Full Text] [Related]
10. A potential in situ gel formulation loaded with novel fabricated poly(lactide-co-glycolide) nanoparticles for enhancing and sustaining the ophthalmic delivery of ketoconazole.
Ahmed TA; Aljaeid BM
Int J Nanomedicine; 2017; 12():1863-1875. PubMed ID: 28331311
[TBL] [Abstract][Full Text] [Related]
11. Central composite designed formulation, characterization and in vitro cytotoxic effect of erlotinib loaded chitosan nanoparticulate system.
Pandey P; Chellappan DK; Tambuwala MM; Bakshi HA; Dua K; Dureja H
Int J Biol Macromol; 2019 Dec; 141():596-610. PubMed ID: 31494160
[TBL] [Abstract][Full Text] [Related]
12. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
13. Design and in vivo evaluation of solid lipid nanoparticulate systems of Olanzapine for acute phase schizophrenia treatment: Investigations on antipsychotic potential and adverse effects.
Joseph E; Reddi S; Rinwa V; Balwani G; Saha R
Eur J Pharm Sci; 2017 Jun; 104():315-325. PubMed ID: 28408348
[TBL] [Abstract][Full Text] [Related]
14. Development of acetazolamide-loaded, pH-triggered polymeric nanoparticulate in situ gel for sustained ocular delivery: in vitro. ex vivo evaluation and pharmacodynamic study.
Singh J; Chhabra G; Pathak K
Drug Dev Ind Pharm; 2014 Sep; 40(9):1223-32. PubMed ID: 23837522
[TBL] [Abstract][Full Text] [Related]
15. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
[TBL] [Abstract][Full Text] [Related]
16. Niosomes: Do They Increase the Potency of Topical Natamycin Ketorolac Formula in Treating Aspergillus Keratitis? An Experimental Study.
El-Mofty HM; El-Nabarawi MA; Abd El Rehem RT; Teaima MH; Abary MYS; Salah M; Lotfy NM
J Ocul Pharmacol Ther; 2020 Sep; 36(7):545-554. PubMed ID: 32357092
[No Abstract] [Full Text] [Related]
17. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel intraarticular injection of diclofenac for the treatment of arthritis: a preclinical study in the rabbit model.
Wen X; Huang X; Wu H
Acta Biochim Pol; 2021 Jan; 68(1):71-76. PubMed ID: 33480230
[TBL] [Abstract][Full Text] [Related]
19. Novel cationic lipid nanoparticles as an ophthalmic delivery system for multicomponent drugs: development, characterization, in vitro permeation, in vivo pharmacokinetic, and molecular dynamics studies.
Wang J; Zhao F; Liu R; Chen J; Zhang Q; Lao R; Wang Z; Jin X; Liu C
Int J Nanomedicine; 2017; 12():8115-8127. PubMed ID: 29158673
[TBL] [Abstract][Full Text] [Related]
20. Positively charged polymeric nanoparticle reservoirs of terbinafine hydrochloride: preclinical implications for controlled drug delivery in the aqueous humor of rabbits.
Tayel SA; El-Nabarawi MA; Tadros MI; Abd-Elsalam WH
AAPS PharmSciTech; 2013 Jun; 14(2):782-93. PubMed ID: 23615773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
